The lack of efficacy in this model was likely due to the absence of significant tumor immune infiltrates (CD4+ and CD8+ T cells) in the Ad.IL-7/B7.1 treatment group compared to the control group [32] (Fig. 2). The gene discussed is CD8A; the disease is neoplasm.